Related Experiment Video
Updated: Jan 21, 2026

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
[Clinical features and TRPM6 mutations of an infant with hypomagnesemia with secondary hypocalcemia]
Zhigang Yang1, Yuan Wang, Guohong Chen
1Department of Neurology, Children' s Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450000, China. yzg19861015@163.com.
Insights
A novel mutation in the TRPM6 gene was identified in an infant with hypomagnesemia and secondary hypocalcemia. This finding expands the known TRPM6 gene mutation spectrum.
Area of Science:
- Genetics
- Molecular Biology
- Pediatric Medicine
Background:
- Hypomagnesemia and secondary hypocalcemia are serious conditions in infants.
- The TRPM6 gene plays a crucial role in magnesium transport.
- Genetic mutations in TRPM6 are a known cause of these electrolyte imbalances.
Purpose of the Study:
- To investigate the clinical presentation of an infant with hypomagnesemia and secondary hypocalcemia.
- To identify the underlying genetic cause, specifically mutations in the TRPM6 gene.
Main Methods:
- Collected clinical data from the affected infant.
- Extracted genomic DNA from the patient and her parents.
- Performed targeted exome sequencing to detect gene mutations.
- Confirmed suspected mutations using Sanger sequencing.
Main Results:
- Identified a novel homozygous c.5538delA (p.Q1846Qfs*2) mutation in the TRPM6 gene in the infant.
- Confirmed that both parents were heterozygous carriers of this mutation.
Conclusions:
- The identified homozygous frameshift mutation in the TRPM6 gene is likely responsible for the infant's condition.
- This discovery broadens the spectrum of known TRPM6 gene mutations associated with disease.
Objective:
To explore the clinical features and mutations of the TRPM6 gene in an infant featuring hypomagnesemia and secondary hypocalcemia.
Methods:
Clinical data of the patient was collected. Genomic DNA was extracted from peripheral blood samples from the patient and her parents. Targeted exome sequencing was carried out to screen the potential mutations. Suspected mutations were verified by Sanger sequencing.
Results:
A novel homozygous c.5538delA (p.Q1846Qfs*2) mutation in the TRPM6 gene was identified in the proband, for which both of her parents were heterozygous carriers.
Conclusion:
The homozygous frameshift mutation of TRPM6 gene (c.5538delA) probably underlies the disease in the proband. The finding has expanded the mutation spectrum of TRPM6 gene.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Myocarditis II: Clinical Features and Diagnostic Tests

